Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
This map shows the geographic impact of G R Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G R Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G R Hughes more than expected).
This network shows the impact of papers produced by G R Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G R Hughes. The network helps show where G R Hughes may publish in the future.
Co-authorship network of co-authors of G R Hughes
This figure shows the co-authorship network connecting the top 25 collaborators of G R Hughes.
A scholar is included among the top collaborators of G R Hughes based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with G R Hughes. G R Hughes is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Bertolaccini, María Laura, Tatsuya Atsumi, T Koike, G R Hughes, & Munther A. Khamashta. (2004). Antiprothrombin antibodies detected in two different assay systems: Prevalence and clinical significance in systemic lupus erythematosus. Research Portal (King's College London). 50(9).4 indexed citations
Cuadrado, M J, Giuseppe D. Sanna, M. K. Sharief, Munther A. Khamashta, & G R Hughes. (2003). Double blind, crossover, randomised trial comparing low molecular weight heparin versus placebo in the treatment of chronic headache. Research Portal (King's College London). 48(9).2 indexed citations
4.
Ferro, Michela, Mohammed Yousuf Karim, I C Abbs, et al.. (2003). Mycophenolate mofetil: A potential treatment for reducing proteinuria associated with membranous lupus nephritis.. Research Portal (King's College London). 48(9).3 indexed citations
Jean, R, María Laura Bertolaccini, Giovanni Sanna, Munther A. Khamashta, & G R Hughes. (2000). Outcome in patients with anticardiolipin antibodies: A prospective 4 years follow-up. Journal of Autoimmunity. 15.2 indexed citations
7.
Hughes, G R, et al.. (2000). Serum antibodies from patients with neuropsychiatric systemic lupus erythematosus cause activation and damage to an in vitro blood-brain barrier model. The Journal of Physiology. 525.
8.
Sanna, Giovanni, et al.. (2000). Prevalence of headache and relationship with the presence of antiphospholipid antibodies in systemic lupus erythematosus. Journal of Autoimmunity. 15.3 indexed citations
Vianna, J. L., H J Haga, R A Asherson, G T Swana, & G R Hughes. (1991). A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus.. PubMed. 18(8). 1193–5.40 indexed citations
13.
Englert, H., S. Loizou, G R Hughes, V R Aber, & Mark Walport. (1986). Livedo reticularis and lupus erythematosus clinical and immunological associations. Lara D. Veeken.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.